Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course

Journal of Infectious Diseases

Volumn 202, Issue 5, 2010, Pages 681-689

  Agrati, Chiara ^a   Gioia, Cristiana ^a   Lalle, Eleonora ^a   Cimini, Eleonora ^a   Castilletti, Concetta ^a   Armignacco, Orlando ^b   Lauria, Francesco Nicola ^a   Ferraro, Federica ^a   Antonini, Mario ^a   Ippolito, Giuseppe ^a   Capobianchi, Maria Rosaria ^a   Martini, Federico ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b BELCOLLE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FAS ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA A (H1N1); MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD95; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON-ALPHA; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; YOUNG ADULT;

EID: 77955668575     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655469     Document Type: Article

References (44)

1. Cohen J. Swine flue outbreak: flu researchers train sights on novel tricks of novel H1N1. Science 2009; 324:870-1.
2. Cohen J, Enserink M. Infectious diseases: as swine flu circles globe, scientists grapple with basic questions. Science 2009; 324:572-3.
3. Cohen J. Swine flu outbreak: past pandemics provide mixed clues to H1N1's next moves. Science 2009; 324:996-7.
4. Cohen J, Enserink M. Swine flu. After delays, WHO agrees: the 2009 pandemic has begun. Science 2009; 324:1496-7.
5. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010; 181:72-9.
6. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302: 1880-7.
7. World Health Organization. Preliminary information important for understanding the evolving situation. Pandemic (H1N1) 2009 briefing note 4. 24 July 2009. http://www.who.int/csr/disease/swineflu/notes/ h1n1-situation- 20090724/en/index.html. Accessed 21 June 2010.
8. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-902.
9. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009; 14:19309.
10. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009; 45:169-73.
11. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-44.
12. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA2009; 302:1872-9.
13. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 1945-52.
14. Cusick MF, Wang S, Eckels DD. In vitro responses to avian influenza H5 by human CD4 T cells. J Immunol 2009; 183:6432-41.
15. Forrest BD, Pride MW, Dunning AJ, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 2008; 15:1042-53.
16. Greenbaum JA, Kotturi MF, Kim Y, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 2009; 106:20365-70.
17. McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309:13-7.
18. Webby RJ, Andreansky S, Stambas J, et al. Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc Natl Acad Sci U S A 2003; 100:7235-40.
19. McElhaney JE, Xie D, Hager WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176: 6333-9.
20. Bender BS, Croghan T, Zhang L, Small PA Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 1992; 175:1143-5.
21. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002; 8:950-4.
22. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin Invest 1998; 101:643-9.
23. Fritz RS, Hayden FG, Calfee DP, et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo- controlled trial of intravenous zanamivir treatment. J Infect Dis 1999; 180:586-93.
24. Lee SM, Gardy JL, Cheung CY, et al. Systems-level comparison of hostresponses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 2009; 4:e8072.
25. Baron S, Isaacs A. Absence of interferon in lungs from fatal cases of influenza. Br Med J 1962; 1:18-20.
26. Link F, Blaskovic D, Raus J. Virus multiplication and interferon formation in lungs from mice infected with A2 influenza virus. Acta Virol 1965; 9:380.
27. Link F, Blaskovic D, Raus J. Relationship between virus multiplication and interferon production in mouse lungs after infection with adapted and unadapted influenza viruses. Acta Virol 1965; 9:95.
28. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938; 27:493-7.
29. Gioia C, Castilletti C, Tempestilli M, et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis 2008; 14:121-8.
30. Criswell BS, Couch RB, Greenberg SB, Kimzey SL. The lymphocyte response to influenza in humans. Am Rev Respir Dis 1979; 120:700-4.
31. Dolin R, Richman DD, Murphy BR, Fauci AS. Cell-mediated immune responses in humans after induced infection with influenza A virus. J Infect Dis 1977; 135:714-9.
32. Lewis DE, Gilbert BE, Knight V. Influenza virus infection induces functional alterations in peripheral blood lymphocytes. J Immunol 1986; 137:3777-81.
33. Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, et al. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009; 4:e8393.
34. Nichols JE, Niles JA, Roberts NJ Jr. Human lymphocyte apoptosis after exposure to influenza A virus. J Virol 2001; 75:5921-9.
35. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290:92-7.
36. D'Offizi G, Montesano C, Agrati C, et al. Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption. AIDS 2002; 16:2431-8.
37. Fesq H, Bacher M, Nain M, Gemsa D. Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology 1994; 190:175-82.
38. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 2000; 74:6105-16.
39. Brincks EL, Kucaba TA, Legge KL, Griffith TS. Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cells. Hum Immunol 2008; 69:634-46.
40. Xie D, Bai H, Liu L, et al. Apoptosis of lymphocytes and monocytes infected with influenza virus might be the mechanism of combating virus and causing secondary infection by influenza. Int Immunol 2009; 21:1251-62.
41. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, Yuen KY. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis 2010; 201:346-53.
42. Kaufmann A, Salentin R, Meyer RG, et al. Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology 2001; 204:603-13.
43. Narasaraju T, Ng HH, Phoon MC, Chow VT. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am J Respir Cell Mol Biol 2010;42:732-43.
44. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009; 4:e8540.